1. Home
  2. KYMR vs WH Comparison

KYMR vs WH Comparison

Compare KYMR & WH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$84.99

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Logo Wyndham Hotels & Resorts Inc.

WH

Wyndham Hotels & Resorts Inc.

HOLD

Current Price

$85.55

Market Cap

6.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
KYMR
WH
Founded
2015
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
6.5B
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
KYMR
WH
Price
$84.99
$85.55
Analyst Decision
Strong Buy
Buy
Analyst Count
26
10
Target Price
$107.72
$94.10
AVG Volume (30 Days)
507.7K
1.1M
Earning Date
04-30-2026
04-29-2026
Dividend Yield
N/A
1.99%
EPS Growth
N/A
N/A
EPS
N/A
2.50
Revenue
$39,211,000.00
$1,429,000,000.00
Revenue This Year
$10.61
$6.86
Revenue Next Year
$8.17
$5.83
P/E Ratio
N/A
$34.42
Revenue Growth
N/A
1.49
52 Week Low
$28.06
$69.21
52 Week High
$103.00
$92.69

Technical Indicators

Market Signals
Indicator
KYMR
WH
Relative Strength Index (RSI) 48.45 54.69
Support Level $77.78 $85.39
Resistance Level $90.15 $88.34
Average True Range (ATR) 3.06 2.32
MACD -0.18 -0.15
Stochastic Oscillator 29.50 51.27

Price Performance

Historical Comparison
KYMR
WH

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About WH Wyndham Hotels & Resorts Inc.

As of Dec. 31, 2025, Wyndham Hotels & Resorts operates 869,000 rooms across more than 20 brands predominantly in the economy and midscale segments. Ramada is the largest brand, representing around 14% of all rooms, with Days Inn (13%) and Super 8 (10%) the next two largest brands, as of the end of 2025. During the past several years, the company has expanded its extended stay/lifestyle brands, which appeal to travelers seeking to experience the local culture of a given location. The company closed its La Quinta acquisition in the second quarter of 2018, adding around 90,000 rooms at the time the deal closed. Wyndham launched a new extended stay economy scale segment concept, ECHO, in the spring of 2022. The United States represented 58% of total rooms in 2025.

Share on Social Networks: